International Seminar: “Moving forwards towards personalized medicine in lysosomal disorders”
25/10/2016
The genetic basis of the phenotypic variability observed in patients can be studied in mice by generating disease models in many different genetic backgrounds where the clinical phenotypes can be assessed and used for genome-wide association studies. Using this strategy putative modifier genes of Gaucher disease were uncovered, leading to the identification of a novel therapeutic strategy for the neuropathic forms of the disease.
Speaker:
Andrés Klein, PhD, Assistant Investigator
Department of Molecular Therapy
Telethon Institute of Genetics and Medicine
Pozzuoli, Italy
Date:
Thursday, October 27th, 2016
Time:
16:00
Location:
Auditorium 4th Floor
Fundación Ciencia & Vida
Avenida Zañartu 1482, Ñuñoa, Santiago
